Table 3.
Drinks per Week |
|||||
---|---|---|---|---|---|
0 | >0 and <1 | ≥1 and <5 | ≥5 and <10 | ≥10 and ≤40 | |
N | 17 | 41 | 81 | 46 | 26 |
Sarcosine | |||||
% change | −5.44 | ref | −1.90 | 21.49 | 138.02 |
95% CIb | −39.36, 47.43 | −27.23, 32.24 | −14.97, 73.57 | 55.52, 264.29 | |
Pvalue | 0.815 | 0.905 | 0.312 | <0.001 | |
Eicosapentaenoate | |||||
% change | −1.56 | ref | 10.46 | 23.52 | 59.87 |
95% CI | −26.80, 32.39 | −9.50, 34.80 | −2.64, 56.71 | 20.36, 112.36 | |
Pvalue | 0.921 | 0.355 | 0.101 | 0.002 | |
4-Androsten-3beta,17beta-diol monosulfate | |||||
% change | −8.43 | ref | 6.01 | 50.68 | 97.88 |
95% CI | −38.58, 36.53 | −18.96, 38.66 | 9.32, 107.67 | 34.96, 190.15 | |
Pvalue | 0.682 | 0.687 | 0.019 | 0.001 | |
4-Androsten-3beta,17beta-diol disulfate | |||||
% change | 10.58 | ref | 3.13 | 53.52 | 123.64 |
95% CI | −26.31, 65.92 | −21.50, 35.48 | 10.82, 112.68 | 51.60, 229.93 | |
Pvalue | 0.646 | 0.834 | 0.015 | <0.001 | |
Gamma-CEHC | |||||
% change | −13.26 | ref | −27.84 | −33.63 | −41.50 |
95% CI | −34.91, 14.89 | −40.75, −13.19 | −47.44, −17.04 | −55.72, −23.68 | |
Pvalue | 0.355 | 0.002 | 0.001 | <0.001 | |
2-Methylcitrate | |||||
% change | −4.85 | ref | −7.58 | −3.25 | 19.51 |
95% CI | −17.84, 9.56 | −16.03, 1.90 | −13.96, 8.41 | 4.09, 37.14 | |
Pvalue | 0.522 | 0.133 | 0.595 | 0.017 |
Results from linear mixed effects regression of individual metabolite concentrations on alcohol intake modeled as a factor with 5 levels and adjusted as described in Table 2 footnote c.
CI=confidence interval